Beta Bionics Shares Rise in Nasdaq Debut

MT Newswires Live

Jan 31

Beta Bionics (BBNX) shares debuted on Nasdaq Thursday with an opening price of $22, above the initial public offering price of $17.

Shares were recently changing hands at $23.28 apiece, up almost 37% from the IPO price.

The stock debuted on the Nasdaq Global Market under the "BBNX" ticker.

The IPO consisted of 12 million shares and the company granted underwriters an option to buy up to an additional 1.8 million shares consisting of 475,000 shares from Beta Bionics and over 1.3 million shares from existing stockholders.

The company said it expects to generate $204 million from the IPO before the overallotment option is exercised.

Price: 23.28, Change: +6.28, Percent Change: +36.91

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2507676187"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2507676187\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2507676187?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-31 01:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2507676187","market":"nz","top_or_hot":-1,"title":"Beta Bionics Shares Rise in Nasdaq Debut","media":"MT Newswires Live","content":"<html><body><p> Beta Bionics (BBNX) shares debuted on Nasdaq Thursday with an opening price of $22, above the initial public offering price of $17.</p><p>Shares were recently changing hands at $23.28 apiece, up almost 37% from the IPO price.</p><p>The stock debuted on the Nasdaq Global Market under the \"BBNX\" ticker.</p><p>The IPO consisted of 12 million shares and the company granted underwriters an option to buy up to an additional 1.8 million shares consisting of 475,000 shares from Beta Bionics and over 1.3 million shares from existing stockholders.</p><p>The company said it expects to generate $204 million from the IPO before the overallotment option is exercised.</p><p>Price: 23.28, Change: +6.28, Percent Change: +36.91</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beta Bionics Shares Rise in Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeta Bionics Shares Rise in Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-31 01:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Beta Bionics (BBNX) shares debuted on Nasdaq Thursday with an opening price of $22, above the initial public offering price of $17.</p><p>Shares were recently changing hands at $23.28 apiece, up almost 37% from the IPO price.</p><p>The stock debuted on the Nasdaq Global Market under the \"BBNX\" ticker.</p><p>The IPO consisted of 12 million shares and the company granted underwriters an option to buy up to an additional 1.8 million shares consisting of 475,000 shares from Beta Bionics and over 1.3 million shares from existing stockholders.</p><p>The company said it expects to generate $204 million from the IPO before the overallotment option is exercised.</p><p>Price: 23.28, Change: +6.28, Percent Change: +36.91</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B64PRP62.GBP","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2507676187","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507676187","pubTimestamp":1738258497,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Beta Bionics  shares debuted on Nasdaq Thursday with an opening price of $22, above the initial public offering price of $17.Shares were recently changing hands at $23.28 apiece, up almost 37% from the IPO price.The stock debuted on the Nasdaq Global Market under the \"BBNX\" ticker.The IPO consisted of 12 million shares and the company granted underwriters an option to buy up to an additional 1.8 million shares consisting of 475,000 shares from Beta Bionics and over 1.3 million shares from existing stockholders.The company said it expects to generate $204 million from the IPO before the overallotment option is exercised.Price: 23.28, Change: +6.28, Percent Change: +36.91","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","NDAQ":"纳斯达克OMX交易所","BK4588":"碎股","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","BK4585":"ETF&股票定投概念",".IXIC":"NASDAQ Composite","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4112":"金融交易所和数据","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BBNX":"Beta Bionics, Inc."},"translate_title":"Beta Bionics在纳斯达克首次亮相股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BBNX":1,"NDAQ":1,".IXIC":1,"NQmain":1},"content_text":"Beta Bionics (BBNX) shares debuted on Nasdaq Thursday with an opening price of $22, above the initial public offering price of $17.Shares were recently changing hands at $23.28 apiece, up almost 37% from the IPO price.The stock debuted on the Nasdaq Global Market under the \"BBNX\" ticker.The IPO consisted of 12 million shares and the company granted underwriters an option to buy up to an additional 1.8 million shares consisting of 475,000 shares from Beta Bionics and over 1.3 million shares from existing stockholders.The company said it expects to generate $204 million from the IPO before the overallotment option is exercised.Price: 23.28, Change: +6.28, Percent Change: +36.91","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}